Novel Ferroptosis-Related Multigene Prognostic Models for Patients with Bladder Cancer

Shun Zhang,* Cheng Wang,* Weimin Xia, Huangqi Duan, Subo Qian, Haibo Shen Department of Urology, Xinhua Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, 200092, People’s Republic of China*These authors contributed equally to this workCorrespondence: Haib...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Zhang S, Wang C, Xia W, Duan H, Qian S, Shen H
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2021
Materias:
Acceso en línea:https://doaj.org/article/8ae1ed9e6e20405691e4f730c8bcc659
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:8ae1ed9e6e20405691e4f730c8bcc659
record_format dspace
spelling oai:doaj.org-article:8ae1ed9e6e20405691e4f730c8bcc6592021-11-23T18:43:01ZNovel Ferroptosis-Related Multigene Prognostic Models for Patients with Bladder Cancer1178-7074https://doaj.org/article/8ae1ed9e6e20405691e4f730c8bcc6592021-11-01T00:00:00Zhttps://www.dovepress.com/novel-ferroptosis-related-multigene-prognostic-models-for-patients-wit-peer-reviewed-fulltext-article-IJGMhttps://doaj.org/toc/1178-7074Shun Zhang,* Cheng Wang,* Weimin Xia, Huangqi Duan, Subo Qian, Haibo Shen Department of Urology, Xinhua Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, 200092, People’s Republic of China*These authors contributed equally to this workCorrespondence: Haibo Shen;Subo Qian Tel +86-13651698392; +86-13761020575Fax +86-21-25078095Email shenhaibo@xinhuamed.com.cn; qiansubo@xinhuamed.com.cnObjective: Bladder cancer contributes to a serious disease burden in clinical settings. The characteristics and prognosis of patients with muscle-invasive bladder cancer (MIBC) and non-muscle-invasive bladder cancer (NMIBC) are distinctly different. The study aims to figure out the respective role of ferroptosis in MIBC and NMIBC and to construct ferroptosis-related gene signatures that could predict patients’ prognoses.Methods: A total of 608 MIBC and 414 NMIBC RNA-seq transcriptome data with intact clinical and follow-up information were downloaded from The Cancer Genome Atlas (TCGA), ArrayExpress, and Gene expression omnibus (GEO) database. Ferroptosis-related multigene prognostic models were constructed and externally validated, respectively, in MIBC and NMIBC. Further functional enrichment analyses were also performed to explicate the underlying mechanisms and the differences between the two bladder cancer subtypes.Results: In MIBC, a 7-gene signature for prognostic prediction was constructed. Patients were then divided into high-risk and low-risk groups according to the risk scores calculated by the 7-gene prognostic model. Patients in the high-risk group presented an impaired OS when compared with patients in the low-risk group both in the training cohort and validation cohort. Further functional analyses revealed distinctly different immune statuses between the two risk-stratification groups, speculating that exhausted immune cell function was a cause of the worst OS in the high-risk group. In NMIBC, 6 ferroptosis-related genes were identified that were significantly correlated with recurrence-free survival (RFS). Similarly, a 6-gene prognostic model was constructed and verified as an independent prognostic predictor for RFS. Functional analyses revealed significant differences in the expressions of nuclear division genes between the high-risk group and low-risk group.Conclusion: Two novel ferroptosis-related multigene prognostic models for, respectively, predicting OS in MIBC and RFS in NMIBC were identified in this study, which indicated ferroptosis played vital roles in the oncogenesis and development of MIBC and NMIBC.Keywords: ferroptosis, bladder cancer, MIBC, NMIBC, prognosis, gene signatureZhang SWang CXia WDuan HQian SShen HDove Medical Pressarticleferroptosisbladder cancermibcnmibcprognosisgene signatureMedicine (General)R5-920ENInternational Journal of General Medicine, Vol Volume 14, Pp 8651-8666 (2021)
institution DOAJ
collection DOAJ
language EN
topic ferroptosis
bladder cancer
mibc
nmibc
prognosis
gene signature
Medicine (General)
R5-920
spellingShingle ferroptosis
bladder cancer
mibc
nmibc
prognosis
gene signature
Medicine (General)
R5-920
Zhang S
Wang C
Xia W
Duan H
Qian S
Shen H
Novel Ferroptosis-Related Multigene Prognostic Models for Patients with Bladder Cancer
description Shun Zhang,* Cheng Wang,* Weimin Xia, Huangqi Duan, Subo Qian, Haibo Shen Department of Urology, Xinhua Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, 200092, People’s Republic of China*These authors contributed equally to this workCorrespondence: Haibo Shen;Subo Qian Tel +86-13651698392; +86-13761020575Fax +86-21-25078095Email shenhaibo@xinhuamed.com.cn; qiansubo@xinhuamed.com.cnObjective: Bladder cancer contributes to a serious disease burden in clinical settings. The characteristics and prognosis of patients with muscle-invasive bladder cancer (MIBC) and non-muscle-invasive bladder cancer (NMIBC) are distinctly different. The study aims to figure out the respective role of ferroptosis in MIBC and NMIBC and to construct ferroptosis-related gene signatures that could predict patients’ prognoses.Methods: A total of 608 MIBC and 414 NMIBC RNA-seq transcriptome data with intact clinical and follow-up information were downloaded from The Cancer Genome Atlas (TCGA), ArrayExpress, and Gene expression omnibus (GEO) database. Ferroptosis-related multigene prognostic models were constructed and externally validated, respectively, in MIBC and NMIBC. Further functional enrichment analyses were also performed to explicate the underlying mechanisms and the differences between the two bladder cancer subtypes.Results: In MIBC, a 7-gene signature for prognostic prediction was constructed. Patients were then divided into high-risk and low-risk groups according to the risk scores calculated by the 7-gene prognostic model. Patients in the high-risk group presented an impaired OS when compared with patients in the low-risk group both in the training cohort and validation cohort. Further functional analyses revealed distinctly different immune statuses between the two risk-stratification groups, speculating that exhausted immune cell function was a cause of the worst OS in the high-risk group. In NMIBC, 6 ferroptosis-related genes were identified that were significantly correlated with recurrence-free survival (RFS). Similarly, a 6-gene prognostic model was constructed and verified as an independent prognostic predictor for RFS. Functional analyses revealed significant differences in the expressions of nuclear division genes between the high-risk group and low-risk group.Conclusion: Two novel ferroptosis-related multigene prognostic models for, respectively, predicting OS in MIBC and RFS in NMIBC were identified in this study, which indicated ferroptosis played vital roles in the oncogenesis and development of MIBC and NMIBC.Keywords: ferroptosis, bladder cancer, MIBC, NMIBC, prognosis, gene signature
format article
author Zhang S
Wang C
Xia W
Duan H
Qian S
Shen H
author_facet Zhang S
Wang C
Xia W
Duan H
Qian S
Shen H
author_sort Zhang S
title Novel Ferroptosis-Related Multigene Prognostic Models for Patients with Bladder Cancer
title_short Novel Ferroptosis-Related Multigene Prognostic Models for Patients with Bladder Cancer
title_full Novel Ferroptosis-Related Multigene Prognostic Models for Patients with Bladder Cancer
title_fullStr Novel Ferroptosis-Related Multigene Prognostic Models for Patients with Bladder Cancer
title_full_unstemmed Novel Ferroptosis-Related Multigene Prognostic Models for Patients with Bladder Cancer
title_sort novel ferroptosis-related multigene prognostic models for patients with bladder cancer
publisher Dove Medical Press
publishDate 2021
url https://doaj.org/article/8ae1ed9e6e20405691e4f730c8bcc659
work_keys_str_mv AT zhangs novelferroptosisrelatedmultigeneprognosticmodelsforpatientswithbladdercancer
AT wangc novelferroptosisrelatedmultigeneprognosticmodelsforpatientswithbladdercancer
AT xiaw novelferroptosisrelatedmultigeneprognosticmodelsforpatientswithbladdercancer
AT duanh novelferroptosisrelatedmultigeneprognosticmodelsforpatientswithbladdercancer
AT qians novelferroptosisrelatedmultigeneprognosticmodelsforpatientswithbladdercancer
AT shenh novelferroptosisrelatedmultigeneprognosticmodelsforpatientswithbladdercancer
_version_ 1718416164594384896